Molecular imaging using magnetic resonance (MR) imaging has been actively investigated and made rapid progress in the past decade. Applied to cancer gene therapy, the technique's high spatial resolution allows evaluation of gene delivery into target tissues. Because noninvasive monitoring of the duration, location, and magnitude of transgene expression in tumor tissues or cells provides useful information for assessing therapeutic e‹cacy and optimizing protocols, molecular imaging is expected to become a critical step in the success of cancer gene therapy in the near future. We present a brief overview of the current status of molecular MR imaging, especially in vivo reporter gene imaging using ferritin and other reporters, discuss its application to cancer gene therapy, and present our research of MR imaging detection of electroporation-mediated cancer gene therapy using the ferritin reporter gene.
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Molecular imaging: Molecular biology meets imaging sciences
Molecular imaging is an emerging scientiˆc discipline that fuses the concepts of molecular biology and imaging sciences and is rapidly growing in thê eld of biomedicine. Although many deˆnitions have been proposed, molecular imaging may best be deˆned as the visual representation, characterization, and quantiˆcation of biological and pathological processes at cellular and molecular levels within living subjects. 1 The technique allows visualization of gene expression, protein-protein interaction, and cell migration in the full biological context of the living organism to provide deep insights into biological processes.
Molecular imaging is an interdisciplinary science that encompasses physics, chemistry, biology, and medicine, and its promotion across theseˆelds demonstrates it as a powerful tool in modern biology and medicine. In fact, the coupling of molecular imaging with recent advances in``-omics'' research, such as genomics and proteomics studies, evidences the promise of these approaches to revolutionize the diagnostic imaging of cancer. 2 Molecular imaging utilizes various imaging modalities, the 3 major methods being optical imaging, MR imaging, and nuclear medicine modalities, such as positron emission tomography (PET) and single photon emission computed tomography (SPECT). The advantages and disadvantages of each modality have been discussed elsewhere. 1, 3 Here, we focus mainly on in vivo reporter gene imaging using 1 H-MRI (but not 13 C-and 19 F-MRI) and its application to cancer gene therapy. Although MR spectroscopy (MRS) is closely related to MR imaging and has also been shown useful in evaluating gene therapy, 4 we do not detail its use here.
MR imaging in molecular imaging
MR imaging is generally accepted to have 2 advantages over other imaging modalities, its high spatial resolution and ability to obtain various physiological and anatomical information by the selection of appropriate pulse sequences. 1 It is also suited to repeated use because of the absence of ionizing radiation. Importantly, it can be applied to humans as well as experimental animals and is widely used for diagnostic imaging of human diseases in a clinical setting. The capacity to translate MR imaging from bench to bed has increased its value in theˆeld of molecular imaging in recent years.
Imaging at high spatial resolution in sub-millimeter range allows visualization of veryˆne structures of tissues and materials, even single cells or particles in the body. For instance, MR imaging can detect single micrometer-sized iron oxide particles in mouse embryos, oŠering new possibilities for in vivo cellular imaging at the single-cell level. 5 MR imaging has also been used to measure functional and physiological parameters, such as pH and temperature, 6 and it has been shown useful in tumor biology for noninvasively characterizing the tumor microenvironment, including tumor vasculature, hypoxia, and cell-cell interaction between cancer cells and their surrounding normal cells, such aŝ broblasts and lymphocytes. 7 This potential of MR imaging to unite anatomical and functional information and provide new insights into the biological processes or pathogenesis of diseases makes it attractive to a broad range of basic and clinical researchers.
MR imaging at higher magneticˆelds is expected to facilitate molecular MR imaging. In the clinical eld, 1.5-tesla MR imaging is commonly used, and 3T imaging has recently come into wide use, improving image quality and resolution and reducing image acquisition time to enhance the modality's usefulness in clinical diagnosis. Use of 8T MR imaging has also been reported. 8, 9 The trend toward MR imaging at higher magneticˆelds will accelerate molecular MR imaging research and have a major impact on molecular imaging. MR imaging has traditionally been considered less sensitive than other modalities, such as PET, SPECT, and optical imaging, and thus somewhat limited and lagging behind in early stages of molecular imaging. Massoud and Gambhir estimated that MR imaging detection requires 10 -3 ¿10 -5 mole/L of contrast agents or probes in target tissues, whereas detection by PET requires 10
mole/L, and optical bioluminescence imaging requires 10
mole/L, implying that MR image acquisition requires administration of much greater amounts of contrast agents. 1 However, recent progress in MR imaging has proposed a highly sensitive method, 10 and Heyn's group has argued that the detection threshold of iron in superparamagnetic iron oxide was not very diŠerent between MR imaging and use of PET tracers. 11 Working with relatively high magnetiĉ elds and using customized hardware and software for small animals or target tissues of interest could also increase the signal-to-noise ratio (SNR) of MR imaging. Nevertheless, low sensitivity remains an issue for careful consideration in molecular MR imaging.
Gene transfer in cancer gene therapy
Demonstration that cancer is caused by multiple alterations of genes critically involved in the regulation of cellular proliferation, survival, or diŠerenti-ation has made gene therapy for cancer one of the most challengingˆelds in basic and clinical research. This therapy basically replaces defective tumor suppressor genes, activates introduced suicide genes, or involves immunomodulation of the host against cancer. 12 In 1990, Rosenberg and colleagues reported theˆrst clinical trial using gene transfer; 13 Viral and non-viral approaches are used to introduce genes into tissues or cells for cancer gene therapy (Table 1 ). Viral vectors have been used extensively because they can achieve highly e‹cient gene delivery into the target tissues. 14 Retrovirus and adenovirus are commonly used in viral vector systems, but their use still presents several problems, including potential for immunogenicity, random insertion and mutagenesis in the genome, uncontrollable chronic expression of the gene, risk of systemic spread, and limitation in terms of the size of the inserted gene. 15 Non-viral delivery is generally safer and simpler than viral delivery, and it is more economical because the production of viral vectors applicable to living subjects, especially to humans, is very expensive and time-consuming. Non-viral delivery methods include lipofection, electroporation (EP), ultrasound, and gene gun, 16 methods that generally have less transfection e‹ciency of transgene delivery into the target tissues, with the result that nonviral delivery has been limited in cancer gene therapy. However, non-viral gene therapy has recently been shown beneˆcial for some malignancies. Electroporation is a physical method for gene delivery, 17 whereby the cell membrane is transiently broken, a pore is formed by electric pulse, and genes are delivered into the cells through the pore. First applied to gene delivery into bacteria and cultured cells, EP was later used in vivo in animals and human subjects. The study of the gene delivery of naked DNA or RNA by EP for cancer has recently grown tremendously. [18] [19] [20] EP-mediated cancer gene therapy has already started, and theˆrst clinical trial was recently reported. 21 Although this procedure is still in its infancy, it will be a promising therapeutic approach for certain malignancies as a new generation of cancer gene therapy.
In vivo reporter gene imaging
Gene expression is the biological process by which a functional gene product, usually protein, is synthesized according to information on the gene. The process includes 2 important steps, transcription and translation. Transcription is the biosynthesis of mRNA from DNA, and translation is thê rst stage of protein biosynthesis, in which amino acids are arranged according to the blueprint of the mRNA.
Measuring gene expression is very important in life science because most biological phenomena appear via the gene expression process. Biochemistry and molecular biology laboratories routinely utilize in vitro reporter assays using reporter genes, such as a luciferase gene, and a standard technique to evaluate gene expression in cultured cells (Fig. 1) . In this method, the reporter gene functions as a surrogate genetic marker for analyzing gene expression and regulation by``reporting'' upstream transcriptional events. Because the regulatory elements, e.g., promoter, of the reporter gene are activated simultaneously when a gene of interest (GOI) is transcribed, reporter protein synthesis, in principle, re‰ects the transcriptional activity of the GOI. Combining the concept of the assay with imaging in the living organism 22 gave rise to in vivo reporter gene imaging, which requires comprehensive knowledge of molecular biology, chemistry, and imaging sciences and represents aˆeld of molecular imaging.
Gene expression in vivo is imaged directly or indirectly. In direct imaging, mRNA or protein, a product of gene expression, is directly targeted by a speciˆc imaging probe labeled with signal molecules, such as radioisotopes or ‰uorescence, to be imaged. A typical example uses labeled antisense oligonucleotides that can hybridize the target molecule. 23 However, application of this methodology to in vivo imaging has been limited because signals are too weak to be imaged. Recently, a new type of direct imaging has been proposed that uses transsplicing ribozyme. 24, 25 Reporter gene imaging, categorized as indirect, is widely used for imaging gene expression in vivo, and various modality-speciˆc reporter genes have been described (Table 2) . 1, 26 Complementary imaging probes developed by coupling with radioisotope, paramagnetic ion, or ‰uorescence can detect reporter transgene expression. For example, in PET, herpes simplex virus type 1 thymidine kinase (HSV1-tk) gene or its mutant form is well characterized (Fig. 2) . [27] [28] [29] The HSV1-TK enzyme phosphorylates its substrates, which are trapped in cells. Substrates labeled with a positron-emitter, such as 18 F and 124 I,``probes,'' or``tracers,'' are adminis- 29 Genes encoding various ‰uores-cence proteins, including green (GFP) and red (RFP) ‰uorescence proteins, 30 and luciferase genes are widely used in optical imaging. RFP and its derivatives remain more favorable than GFP for in vivo study because of their superior tissue penetration. Because these reporter proteins emit ‰uores-cence when excited, use of other images probes is unnecessary. Luciferase gene is another reporter gene in optical imaging; 31ˆr e‰y and Renilla lu-ciferase genes are most commonly used and require their speciˆc substrates for signal production. However, optical reporter gene imaging has been limited to animal application. We detail reporter genes for MR imaging in the following section. Reporter gene imaging is used for various purposes; as mentioned, imaging of in vivo gene expression may be a primary focus. Therefore, these techniques have been applied to noninvasive monitoring of transgene expression in gene therapy. 32 Alternatively, Gambhir's group demonstrated imaging of protein-protein interaction using a split luciferase reporter (Fig. 3) . 33 Reporter gene imaging also promises to be a powerful tool in theˆeld of regenerative medicine. For example, Wu and colleagues reported imaging of transplantation of murine embryonic stem (ES) cells stably expressing reporter genes in the myocardium of the adult nude rat, suggesting that stem cells could be labeled with a suitable reporter and cell fate monitored noninvasively. 34 
MR imaging reporter genes
Various MR imaging reporter genes have been proposed (Table 2 ). Bulte and colleagues classiˆed 3 categories of MR imaging reporters-enzymebased, chemical exchange saturation transfer (CEST)-based, and iron-based. 35 b-Galactosidase, encoded by the bacterial gene lacZ, is suggested as an enzyme-based MR imaging reporter gene and has long been used to assess gene transfer and its expression in vivo as well as in vitro with colored substrates. 36 Taking advantage of its well established chemical reactions, gadoliniumbased MR imaging contrast agents were designed that function as substrates for b-Galactosidase. Overexpression of b-Galactosidase in cells cleaves oŠ the galactose group of the substrate and exposes a free coordination site of the gadolinium ion. This leads to the water proton's increased access to the metal ion, which results in inner sphere relaxation enhancement and increased MR contrast on T 1 -weighted images (T 1 WI). 37 The absence of endogenous b-Galactosidase expression oŠers this system the advantage of low background.
The human tyrosinase gene is another example of an enzyme-based reporter. Unlike most tumors, melanotic melanomas commonly have high signal intensities on T 1 WI, which is attributed to the high a‹nity and binding capacity of melanin for metal ions. 38 This characteristic raises the possibility that tyrosinase, a key enzyme-producing melanin, could be a reporter gene for MR imaging. In fact, increased signal intensity on T 1 WI has been reported in transfected cells overexpressing tyrosinase gene when cultured with iron-and holotransferrin-enriched medium. 39 Chemical exchange saturation transfer is a new method of generating MR contrast that relies on the chemical exchange of protons of solutes with bulk water, which reduces MR imaging signal intensity. 40 Gilad and associates 41ˆr st described a lysine-rich protein (LRP) gene, a CEST-based reporter gene, detecting LRP-expressing xenografts in mouse brain. The CEST-based reporter gene is of particular interest because it is can be switched and would allow``multicolor'' imaging. 42 Iron-binding proteins are potential reporter candidates for MR imaging because iron can act as a paramagnetic reactive metal. Weissleder and colleagues 43 described the use of transferrin receptor (TfR) gene as such a reporter (Fig. 4) , administering transferrin-monocrystalline iron oxide nanoparticle (Tf-MION) and imaging its expression in tumor xenografts on T 2 -weighted image (T 2 WI). Although the TfR gene reporter system provides MR imaging contrast, there is concern that TfRdependent iron uptake could induce cell toxicity. 44 Ferritin, a major intracellular iron-binding protein, is a candidate for this type of reporter gene and has been shown as a reliable reporter transgene for MR imaging. The ferritin reporter will be detailed in the following section.
Recently, magA, a bacterial iron transporter, has been shown to work as an MR imaging transgene reporter. Zurkiiya's group reported in vivo visualization of the induced expression of magA gene on T 2 -or T 2 *-weighted image with endogenous iron. 45 They stated that cells expressing magA showed an approximately 3-to 4-fold increase in 1/T 2 compared to the approximately 2.5-fold increase of 1/ T 2 in cells expressing ferritin, albeit under diŠerent experimental conditions. The magA reporter system is of particular interest but has been reported only sparsely.
Ferritin: an attractive molecule in biology and molecular imaging
Ferritin is a major iron storage protein that is expressed ubiquitously in cells. 46 Typical ferritin proteins comprise 24 subunits and form a spherical shell. In vertebrates, the protein consists of 2 subunits, heavy (FTH) and light chains (FTL). The protein serves mainly for iron storage to maintain iron homeostasis but has many other proposed functions, which include control of oxidative stress, regulation of protein translation, inhibition of apoptosis, and anti-angiogenesis. The protein has been related to the development of some human disorders, such as anemia, neurodegenerative disease, and cancer. A well known example in theˆeld of neurology is neuroferritinopathy, an autosomal dominant disease with iron accumulation caused by a mutation of the FTL gene. 47 In cancer, we reported that the FTH protein was involved in the pathogenesis of asbestos-induced mesothelioma. 48 Long study of the biology of ferritin has shown that the protein is a versatile molecule, and some novel function may yet be discovered. Ferritin, therefore, remains an interesting protein for investigation and not a``rusty'' molecule. The reader is referred to an excellent recent review of ferritin. 49 In theˆeld of molecular imaging, ferritin has been proposed as a reporter protein to visualize gene expression in vivo by MR imaging. Two pioneer works reported in 2005 highlighted the ferritin gene as a reliable transgene reporter for MR imaging. Cohen and associates reported that induced expression of murine FTH gene resulted in a shortening of T 1 and T 2 MR relaxation times in C6 glioma cells, 50 and they visualized induced ferritin gene expression in C6 tumors on T 2 WI (Fig. 5 ). Genove's group introduced human FTH and FTL genes into mouse brain by adenovirus vectors and visualized their transgene expression by 7T MR imaging. 51 Soon after, Deans and colleagues described the possibility of a combined reporter system of transferrin receptor and ferritin to improve cellular contrast. 52 54 Although the ferritin transgene reporter has been demonstrated as a possibly useful tool in various tissues or cells, the principle of MR imaging detection seems to be complex. Overexpression of the ferritin gene is thought to provide contrast by transiently lowering intracellular iron concentration, which leads to up-regulation of the transferrin receptor to compensate for the state of deˆciency and triggers uptake of cellular iron. 51 Cohen's group has also stated that redistribution of intracellular iron between ferritin molecules is important in the signal change of ferritin reporter gene. 50 Molecular MR imaging of EP-mediated transgene expression in tumors using ferritin reporter gene
Recently, we reported a new method for visualizing electroporation-mediated transgene expression in tumors by MR imaging using ferritin reporter gene (Fig. 6) . 55 We aimed to develop a simple, safe, and reliable method for monitoring transgene expression in tumors noninvasively, without admin- 55 ) istering exogenous contrast agents, in the setting of cancer gene therapy mediated by in vivo EP. Wê rst utilized optical imaging to assess EP-mediated transgene expression in tumors, introducing a mammalian expression vector carrying a gene encoding DsRed, a red ‰uorescence protein, into xenografted subcutaneous tumors in nude mice by EP. We detected transgene expression one day after EP, and signal intensity peaked at day 6 to 7 and gradually decreased. We could detect the signal for 2 and, in some cases, 3 weeks. This in vivo ‰uores-cence monitoring provided us with a basis for understanding the kinetics of transgene expression mediated by in vivo EP.
We next constructed an internal ribosome entry site (IRES)-based dual mammalian expression vector carrying human fth and DsRed ‰uorescence protein gene, a vector that allows monitoring of fth expression by DsRed ‰uorescence. In vitro experiments revealed that overexpression of fth genes resulted in T 2 shortening in human 293T cells and that the cells were darkened in T 2 WI. After we conrmed that FTH transgene reporter expression led to T 2 shortening in the cells, we investigated whether EP-mediated transgene expression of FTH reporter gene was visualized by MR imaging in vivo in tumors. When we introduced fth genes into 293T xenografted tumors by EP, we detected FTH reporter transgene expression on T 2 WI as areas of hypointensity that correlated well with DsRed ‰uorescence. We thereby succeeded in imaging intratumoral transgene expression of FTH reporter genes by MR imaging using endogenous iron with high spatial resolution.
Conclusions and Perspectives
The ferritin reporter system is advantageous by using endogenous iron and avoiding the use of contrast agents for in vivo imaging, and no obvious detriment or toxicity has been observed with overexpressed ferritin in cells. Therefore, the system is smarter, simpler, and safer than other systems. Although the safety and e‹cacy of the ferritin transgene reporter must be validated more carefully in animal models, we believe the system is principally translatable to human gene therapy for cancer and other diseases.
However, the relatively low 1/T 2 of ferritin at typical magneticˆeld strengths 56 requires its further improvement in sensitivity to facilitate the system's wider use. Because 1/T 2 in ferritin solution increases linearly withˆeld strength, the use of MR imaging scanners with ever higher magneticˆelds is of particular interest. 57 Koretsky's group has also proposed that aggregation of ferritin by binding to cytoskeletal elements may increase 1/T 2 , which would be a way to improve sensitivity. 58 So far, most eŠorts in in vivo reporter gene MR imaging have centered on animal studies to providè`p roof-of-principle'' evidence, and there is little information on clinical outcome. Nevertheless, there is no doubt that these eŠorts have proved that the technique can contribute to cancer gene therapy by permitting the monitoring of gene delivery and transgene expression in vivo. We speculate that more sophisticated molecular MR imaging studies will further accelerate cancer gene therapy. Molecular MR imaging is more and more realistically approaching the vanguard for cancer gene therapy.
